On the other hand, increased levels of the circulating proconvertase subtilisin-kexin 9 (PCSK9) are found in patients with type 2 diabetes, obesity and CVD and are associated with CVD severity14–18. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.